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Abstract
Few studies have examined the epidemiology of respiratory viral infections in large tertiary centres over more than one season in the era
of molecular diagnosis. Respiratory clinical specimens received between 1 January 2011 and 31 December 2012 were analysed.
Respiratory virus testing was performed using a large panel of real-time PCR or RT-PCR. Results were analysed according to sample type
(upper versus lower respiratory tract) and age group. In all, 2996 (2469 (82.4%) upper; 527 (17.6%) lower) specimens were analysed.
Overall positivity rate was 47.4% and 23.7% for upper and lower respiratory samples, respectively. The highest positivity rate was
observed in patients under 18 years old (p <0.001); picornaviruses were the most frequent viruses detected over the year. Inﬂuenza
virus, respiratory syncytial virus, human metapneumovirus and coronaviruses showed a seasonal peak during the winter season, while
picornaviruses and adenoviruses were less frequently detected in these periods. Multiple viral infections were identiﬁed in 12% of positive
cases and were signiﬁcantly more frequent in children (p <0.001). In conclusion, we observed signiﬁcant differences in viral infection rates
and virus types among age groups, clinical sample types and seasons. Follow-up of viral detection over several seasons allows a better
understanding of respiratory viral epidemiology.
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Introduction
Respiratory viral infections are a leading cause of morbidity
and mortality, particularly in children, the elderly and
immunocompromised persons. Rapid identiﬁcation of viral
aetiology is critical to avoid unnecessary antibiotics, to initiate
antiviral treatment when available and to limit the spread of
the infection [1].
Nucleic acid-based ampliﬁcation tests (NATs) allow sensitive
detection of a broad panel of both conventional and emerging
viruses in respiratory tract specimens. NATs are more sensitive
than any other diagnostic method, including virus isolation in cell
culture and antigen detection, and now form the backbone of
clinical virology laboratory testing around the world. This
advance has changed the landscape of virus detection and
highlights the need to better understand the epidemiology of
viruses ranging from rhinoviruses to inﬂuenza virus [2,3].
Most of the available literature describing the epidemiology
of respiratory viruses is focused on the paediatric population,
other particular populations, or speciﬁc viral agents; studies
are frequently limited to one season. A longitudinal examina-
tion of the epidemiology of viral respiratory agents among
patients frequenting a large university centre is lacking;
prevalence patterns in this group may differ from those in
the community and may be subject to seasonal variation.
Our study aims to describe the general molecular
epidemiology of viral respiratory infections in paediatric, adult
and elderly populations admitted to or screened in a tertiary
care centre over a 2-year period, and, more speciﬁcally, to
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compare the epidemiological patterns of upper and lower
respiratory specimens.
Methods
The University Hospital of Geneva is a tertiary care teaching
hospital with 1600 acute-care beds and >40 000 admissions
each year. It is comprised of surgical and internal medicine
services, as well as bone-marrow and solid-organ transplant
units. The virology laboratory of the University Hospital of
Geneva processes all clinical specimens from adult and
paediatric inpatient and outpatient departments.
Clinical specimens
All respiratory specimens (nasopharyngeal swabs and aspi-
rates, bronchial and/or tracheal aspirates and bronchoalveolar
lavage (BAL) specimens) from adult and paediatric inpatients
and outpatients received between 1 January 2011 and 31
December 2012 were included in the study. Nasopharyngeal
swabs and aspirates were grouped as ‘upper respiratory
samples’, while bronchial and tracheal aspirates, as well as BAL
specimens, were considered ‘lower respiratory samples’.
Further, specimens were considered ‘paediatric’ if they were
from patients under 18 years of age, ‘adult’ if from patients
between 18 and 65 years old, and ‘elderly’ if from patients
over age 65. Collection of samples for analysis was not
systematic but was based on clinical judgement according to
local practice and guidelines that recommend viral screening in
patients at risk of lower respiratory complications and
systematically in transplant recipients, in hospitalized patients
with an acute respiratory disease during the inﬂuenza season,
and in those that do no respond to the usual empirical
antibiotic treatment. However, detection of viral pathogens
was systematic in BAL obtained from immunocompromised
patients such as transplant recipients.
Viral real-time PCR detection
Each specimen was screened by nucleic acid detection for the
presence of inﬂuenza A (both seasonal and 2009 pandemic
H1N1 strains) or B virus, respiratory syncytial virus (RSV) A
and B, parainﬂuenza virus 1–3, human metapneumovirus,
rhinovirus A, B and C, enterovirus, adenovirus and, beginning
on 23 August 2011, coronaviruses 229E, OC43, HKU1 and
NL63. Screening was performed using individual one-step
real-time Taqman©-based PCR or RT-PCR as described
previously. Respiratory specimens were extracted using
Easymag© (bioMerieux, Geneva, Switzerland) according to
the manufacturer’s recommendations. The viral real-time PCR
detection was performed as described for parainﬂuenza
viruses 1 and 3 [4], inﬂuenza viruses, RSV A and B,
coronaviruses, parainﬂuenza virus 2, human metapneumovirus,
coronaviruses, adenoviruses [5, 6] enteroviruses and
rhinoviruses [7].
Extraction, presence of PCR inhibitors, and reverse
transcription were controlled by spiking each specimen with a
quantiﬁed standard of canine distemper virus; experiments were
validated only if the resulting cycling threshold value was within
the expected ranges. PCR detection was considered positive if
the cycling threshold value was ≤39.
In addition to molecular tests, rapid tests for antigen
detection (data not shown) are routinely used for inﬂuenza A
and B viruses (Bionexia; bioMerieux, Lyon, France) and RSV
(Quickvue; Quidel, San Diego, CA, USA) detection in the
paediatric emergency wards.
Deﬁnition of clinical episodes
For patients with specimens that were repeatedly positive for
the same viral agent in a period shorter than 3 weeks, only the
ﬁrst positive result was considered. If the interval between
positive specimens was 3 weeks or longer, a different episode
was assumed. A separate clinical episode was also assumed for
patients with different viruses detected throughout their
clinical course, independent of the time elapsed between
sampling. If two upper or two lower respiratory samples were
sent at the same time or within 3 days of one another, these
were considered a single clinical episode if both were positive.
Simultaneous detection of more than one virus in the same
sample was considered as a single clinical episode with a
multiple viral infection (MVI).
Statistical analysis
The independent t-test was used to compare continuous data,
while the chi-squared test was used to compare categorical
data. Associations with a p value <0.05 were considered
signiﬁcant. All data were analysed within IBM SPSS Statistics for
Windows, Version 20.0 (IBM Corp, Armonk, NY, USA).
Results
During the study period, 2996 clinical respiratory specimens
were analysed, with a total of 32 387 real-time PCRs or
RT-PCRs performed. Upper respiratory samples predomi-
nated, representing 82.4% of all cases (2469); 17.6% (527)
were lower respiratory samples. Among the 527 lower
respiratory samples, 451 (85.6%) were collected via BAL.
The overall positivity rate (PR) for any respiratory virus was
43.2%, while for upper and lower respiratory samples it was
47.4% and 23.7%, respectively (Fig. 1). Most (89%) nasopha-
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ryngeal aspirates were collected from paediatric patients,
whereas most (87.9%) nasopharyngeal swabs were drawn from
adult and elderly patients. For coronaviruses, 328 upper and 72
lower respiratory samples were analysed.
The proportion of specimens from male patients ranged
from 47.4 to 64.7% depending on the population. The
distribution of samples and the positivity rate according to
age group are shown in Table 1. Median ages were 2 years
(range 0–18 years), 41.5 years (range 18–65 years) and
84.5 years (65–103 years) for paediatric, adult and elderly
populations, respectively. Lower respiratory samples were
collected from both genders fairly equally among adult patients
(47.4% male) but primarily from male patients among the
elderly (63%). Overall, lower respiratory samples were
collected chieﬂy from adults (51.2%), with only 26.2% and
22.6% from paediatric and elderly patients, respectively. Upper
respiratory samples were somewhat more evenly distributed,
with 26.1%, 36.6% and 37.3% from paediatric, adult and elderly
populations, respectively. The highest positivity rate (78.6%)
was found in upper respiratory samples collected from
paediatric patients, the lowest (20.4%) in lower respiratory
samples from adult patients. Paediatric patients had a signif-
icantly higher positivity rate (p <0.001).
Of 527 lower respiratory samples, 69 (13.1%) had a paired
upper respiratory sample analysed during the same episode.
Among these, 20 (29%) were both positive, 39 (56.5%) were
both negative, and ten (14.5%) had discordant results.
Fig. 2 describes the respective prevalence of different types
of viruses. Picornaviruses were detected with the greatest
frequency in all specimens and populations except upper
respiratory samples collected from the elderly; in these,
inﬂuenza viruses predominated. Indeed, across all specimens,
inﬂuenza virus prevalence increased with patients’ age. Para-
inﬂuenza viruses were the second most frequently found
viruses in lower respiratory samples of the elderly population,
whereas overall, adenoviruses were very infrequent in the
non-paediatric population. Among children, adenoviruses and
RSV were the second and third most frequent viruses, both for
upper and lower respiratory samples. In contrast, coronav-
iruses were rarely found in children, but were detected in
9–16% of combined specimens in adults and the elderly.
Multiple viral infections, deﬁned as the simultaneous detec-
tion of more than one virus in one clinical specimen, were
apparent in 141 (12%) and 14 (11.3%) of all positive upper and
lower respiratory samples, respectively. Among the 141 positive
upper respiratory samples, 123 (87.2%) were positive for two
viruses, 16 (11.4%) for three viruses and two (1.4%) for four
viruses, 14 lower respiratory samples were positive for two
viruses. MVI diagnosed via upper respiratory samples were
signiﬁcantly more frequent among paediatric patients: 13.5% of
paediatric samples revealed multiple viruses versus 2.5% and
3.4% of adult and elderly samples, respectively (p <0.001).
2996 clinical respiratory specimens 
screened for respiratory  viruses
2469 (84.2%) upper respiratory 
specimens a *
527 (17.6%) lower respiratory 
specimens b *
1171 positive 
(47.4%) 
1298 negative 
(52.6%) 
125 positive 
(23.7%) 
402 negative 
(76.3%) 
1030 (88%) 
positive for  
one virus
141 (12%) 
positive for
multiple viruses
111 (89.5%) 
positive for
one virus
14 (11.5%) 
positive for 
multiple viruses
<18 years old, n = 87
18-65 years old, n = 23
>65 years old, n = 31
<18 years old, n = 9
18-65 years old, n = 2
>65 years old, n = 3
FIG. 1. Clinical respiratory specimens
analysed during the study period (1
January 2011 to 31 December 2012).
aNasopharyngeal swabs and nasopha-
ryngeal aspirates. bTracheal and/or
bronchial aspirates and bronchoalveolar
lavages *In 69 cases there were paired
upper and lower respiratory specimens for
the same episode.
TABLE 1. Type, distribution and positivity rates of clinical
respiratory specimens collected during the study period
stratiﬁed by age
Respiratory specimen
Paediatric Adults Elderly
n PR (%) n PR (%) n PR (%)
Uppera
n = 2469
645 78.6 904 44.6 920 46
Lowerb
n = 527
138 40.6 270 20.4 119 23.5
PR, positivity rate.
aIncludes nasopharyngeal swabs and nasopharyngeal aspirates.
bIncludes tracheal/bronchial aspirates and bronchoalveolar lavages.
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Among upper respiratory samples from children, the most
frequent co-infections were picornaviruses with adenoviruses
(22 cases, 15.4%) and adenoviruseswithRSV (ten cases, 7%). The
former was also the most frequent co-infection detected among
lower respiratory samples. Details of MVI are shown in Table 2.
The number of screened specimens increased in winter
periods but the positivity rate, although also slightly higher in
winter months, remained relatively stable (Fig. 3a). The highest
positivity rate was obtained in February 2012 (76.5%) and the
lowest in August 2012 (25.4%). Regarding the distribution of
respiratory viruses over the year, nﬂuenza virus, RSV, human
metapneumovirus and coronaviruses showed a clear seasonal
pattern, with a marked increase in PR throughout the winter
months, while picornavirus and adenovirus prevalence remained
relatively stable over the year, with a decrease in the PR during
winter months. Seasonal prevalence patterns are depicted in
Fig. 3b. For multiple infections, the cases with simultaneous
detection of picornaviruses and adenoviruses were found
throughout the year, whereas those involving inﬂuenza viruses
and coronaviruses were more frequent in winter.
Discussion
We describe the epidemiological patterns of respiratory
viruses among hospitalized and ambulatory patients of all
ages screened at a tertiary care centre across all seasons of
a 2-year period. Overall, the positivity rate for any
respiratory virus was 43.2% and it was signiﬁcantly higher
in the paediatric population. Picornaviruses had the highest
prevalence. Co-infections with more than one virus were
relatively uncommon; they were detected most frequently in
paediatric samples (13.5% of positive cases). The main
strengths of our investigation are the high number of
specimens analysed as well as the use of ‘real-life’ data; these
results are likely to reﬂect the epidemiology of respiratory
viruses as observed by clinicians delivering routine care in a
tertiary care centre and for a wide age range. The increased
sensitivity of molecular diagnostic methods, provides a more
faithful depiction of the epidemiology of respiratory viruses
at the ‘front line’, where patients with a higher risk of
complications are hospitalized. Our results suggest that
viruses circulating in large hospitals parallel those observed
in the community.
We observed the highest positivity rate in the paediatric
population, with overall prevalence reaching nearly 80%. This
could partially be explained by the frequent collection of
nasopharyngeal aspirates rather than swabs, as the former may
be more sensitive [8]. However, it has also been established
that the viral load in children is signiﬁcantly higher than in
adults, and our results are comparable to other studies in
children that used swabs. Khamis et al. reported a PR of 50% in
nasopharyngeal aspirates from the paediatric patients of an
Omani hospital using multiplex PCR. In this study, the most
prevalent virus was RSV, but the study population was limited
to children under 5 years old [9]. Another large, prospective
study following paediatric patients for 2 years and employing
real-time RT-PCR also detected RSV most frequently, but
again patients were young (<2 years) with suspected pneu-
monia [10]. In our study, picornaviruses were most frequently
detected in the paediatric population. Varying outcomes
among studies reﬂect their differences in diagnostic technique,
the clinical criteria applied to the study population, and the
panel of detected viruses. These heterogeneities render
FIG. 2. Viral prevalences according to
age group (<18, 18–65 and >65 years old)
in all respiratory specimens collected
during the study period. hMPV, human
metapneumovirus; PIV, parainﬂuenza
virus; RSV, respiratory syncytial virus.
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comparisons among published studies difﬁcult, if not altogether
misleading.
In our study, multiple viral infections were observed in
>10% of positive cases overall, and almost 15% of positive
paediatric cases. Other studies, however, have shown even
higher rates of co-infections. In the study by Khamis et al. [9],
MVI were found in 18% of cases. Zhang et al. [11] reported a
rate of 29.5% in children younger than 3 years old, while
Kouni et al. [12] reported an MVI rate of 42.5% in children
between 1 month and 14 years old, as detected by DNA/RNA
microarray assay. Although the clinical impact of multiple
infections is unknown, a more severe clinical course was
observed in the latter study [12]. It is also unclear whether
infection with the ﬁrst virus may facilitate or prevent infection
with other viruses. In the present study, picornaviruses were
those most frequently involved in co-infections, which is
certainly related to the fact that picornaviruses are detected
throughout the year and are the most prevalent. It is also
possible, however, that picornavirus serotypes vary over the
year; some of these might manifest a seasonal pattern, variable
virulence and/or the capacity to predispose their host to
additional viral infections. The most frequent co-infection was
with picornaviruses and adenoviruses. Not surprisingly, this
association was consistent throughout the year, whereas the
MVI involving inﬂuenza virus, RSV or coronaviruses were more
frequently found in winter.
Moreover, a positive detection by NATs does not neces-
sarily signify active replication, because it might be the remnant
traces of a recent infection. Hence, an infection following a
previous one with still-detectable nucleic acid cannot be
excluded. Alternatively, detection of multiple respiratory
viruses might be a surrogate marker of immunosuppression,
as persistent infection has been described for several respira-
tory viruses in immunocompromised patients [13]. Finally, it
seems that co-detection of different respiratory viruses is not
random. A recently published study showed that there were
positive and negative associations between some viruses. For
example, rhinoviruses and adenoviruses were positively asso-
ciated whereas inﬂuenza A virus and rhinoviruses showed a
negative association [14]. Of note, in our study inﬂuenza virus
was almost completely absent among the viruses involved in
co-infections in the paediatric population, in which picornav-
iruses were very prevalent.
Seasonality is well described for several viral respiratory
pathogens. Existing evidence suggests that the seasonality of
some pathogens may be driven by enhanced wintertime
survival, and also by increased host susceptibility resulting from
relative ‘wintertime immune suppression’ [15]. A cold
environment decreases innate defence mechanisms such as
mucociliary clearance, so increasing susceptibility to viral
infections [16]. In a large Malaysian study performed over
27 years and with >10 000 respiratory samples, while RSV and
TABLE 2. Multiple respiratory viral infections detected during the study period
Upper respiratory samplesa Lower respiratory samples
<18 yearsb n Positive for two viruses n Positive for two viruses
22 Picornavirus Adenovirus 6 Picornavirus Adenovirus
10 Adenovirus RSV 1 Picornavirus RSV
9 Picornavirus RSV 1 Picornavirus PIV
5 Picornavirus PIV 1 RSV PIV
4 Adenovirus hMPV
4 Adenovirus PIV
3 Adenovirus PIV
3 Adenovirus Coronavirus
3 RSV Coronavirus
n Positive for three viruses
3 Picornavirus PIV Adenovirus
2 Picornavirus RSV Adenovirus
2 Picornavirus RSV Coronavirus
18–65 years n Positive for two viruses n Positive for two viruses
3 Picornavirus RSV 1 Picornavirus Coronavirus
2 Picornavirus Inﬂuenza virus 1 Picornavirus PIV
2 Picornavirus Coronavirus
n Positive for three viruses
2 Picornavirus RSV Inﬂuenza virus
>65 years n Positive for three viruses n Positive for two viruses
7 Inﬂuenza virus Coronavirus 1 Picornavirus Adenovirus
4 Picornavirus Inﬂuenza virus 1 Coronavirus Inﬂuenza virus
2 RSV Inﬂuenza virus
hMPV, human metapneumovirus ; PIV, parainﬂuenza virus; RSV, respiratory syncytial virus.
aOnly the multiple infections with associations found in more than one case are shown.
bThere were two cases of multiple infections with four viruses detected in this group (upper respiratory specimens, <18 years, one case of picornavirus–adenovirus–PIV2–PIV3
co-infection and one case of adenovirus–hMPV–PIV–inﬂuenza virus co-infection).
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other, less frequent viruses produced peaks throughout the
year, they spiked more notably from September to December,
correlating with the rainy season [17]. For those viruses
showing seasonal patterns, the months in which the peaks
occur may be determined by local topography and latitude,
making comparisons among studies performed in different
countries difﬁcult [18].
In our study, picornaviruses had the highest prevalence over
all seasons, although other viruses such as inﬂuenza virus and
RSV increased their prevalence in winter. The reasons why
picornaviruses and adenoviruses display no discernible seasonal
patterns are poorly understood. As expected, we found that
inﬂuenza viruses and other viruses increase in prevalence with a
seasonal distribution in winter (see Fig. 3b). In these periods,
picornaviruses and adenoviruses were less frequently detected.
Whether picornaviruses delay inﬂuenza circulation or whether
the initiation of inﬂuenza circulation decreases the prevalence of
picornaviruses is not clear either. It has been suggested that
rhinovirus infection might protect against inﬂuenza virus infec-
tion either through viral interference at the cellular level or via
interferon or other cytokines. Indeed, it has been hypothesized
that in some countries such as France and Norway, rhinovirus
circulation delayed the spread of pandemic H1N1 inﬂuenza in
2009 [19,20]. As noted above, a recent study showed a negative
association between inﬂuenza A virus and rhinovirus co-infec-
tion [14].
On a practical level, whether a complete respiratory panel
needs to be employed for viral detection in summer months is
unknown. The approach should probably be adapted to the
local epidemiology of each particular centre. In Geneva, a city
with a continental climate and inhabitants who travel
internationally with relative frequency, employing a complete
panel year-round appears justiﬁed, despite a low detection of
some viruses. However, as shown in Fig. 3a, despite a slight
decrease of PR in summer months, overall PR for respiratory
viruses remained relatively stable throughout the year. A
complete respiratory viral panel would also be appropriate for
immunocompromised patients, particularly lung transplant
recipients or children with chronic pulmonary diseases. The
additional costs incurred by the use of a complete panel would
likely be offset by the attendant reduction in unnecessary
hospitalizations and antibiotic therapy.
Our study has some limitations. First, the analysis is
limited to the data available in our laboratory; no clinical
end-points were included. A positive result from an upper
respiratory sample (e.g. nasopharyngeal aspirate) may
represent an upper respiratory infection or a lower one
(bronchiolitis for example), hence upper respiratory sampling
(a)
(b)
FIG. 3. (a) Numberofpositiveandnegative
respiratory clinical specimens received and
analysed at the Laboratory of Virology of the
University of Geneva Hospitals during the
study. (b) Positivity rate for each group of
viruses fromclinical specimens analysed at the
Laboratory of Virology of the University of
Geneva Hospitals during the study period.
hMPV, human metapneumovirus; PIV,
parainﬂuenza virus; RSV, respiratory syncytial
virus.
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does not guarantee an upper respiratory infection. Second,
pooled data from bacterial and fungal testing were not
available; these would have been particularly illuminating
among immunocompromised patients. In addition, the prev-
alence of RSV may be underestimated in our study: because
a rapid test for RSV antigen detection is available in our
centre in the paediatric emergency wards: not every child
with suspected RSV infection was tested by NATs. This may
explain, in part, why picornaviruses were detected more
frequently in the present study, whereas most other studies
report RSV as the most frequent virus in children. Finally,
the proportion of immunocompetent and immunocompro-
mised patients is not known; we offer an analysis of the
whole population (ambulatory and hospitalized, immunocom-
petent and immunocompromised).
Our study provides an overview of viral respiratory
infections in a large tertiary centre. Picornaviruses are the
most frequently detected respiratory viruses among paediatric,
adult and geriatric populations, although inﬂuenza virus
predominated in the latter. Inﬂuenza virus, RSV and human
metapneumovirus display a seasonal pattern, whereas picor-
naviruses and adenoviruses are detected with regularity
throughout the year. Multiple infections are commonly
observed in children, although their overall prevalence is
relatively low. A clearer picture of respiratory virus prevalence
patterns across all seasons and age groups aids in the design of
diagnostic strategies and can help to reduce unwarranted
antimicrobial consumption.
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